Close
Open Nav

Sunday, June 2, 2019 

This one-day, intense course will give participants the background knowledge on how pharmacoepidemiology is used to influence drug policy in the US and how this policy affects pharmacoeconomics in this country. Industry expert Dr. Shane Desselle will explain the complex relationship between drug manufacturers, govt policy, insurers, pharmacies, employers and patients that drives drug pricing and reimbursement decisions in the US. This course is ideal for anyone in government, finance, law, insurance or human resources.

Course Agenda

Drug Placement onto Formularies 9:00-10:15

  • Drug Formularies Defined
  • Types of Formulary Systems
  • Medicare, Medicaid, Private Insurers
  • Single Payer Markets
  • Considerations/Issues for Placement
  • Value Proposition and Price
  • Manufacturer Rebates
  • Tiering Systems
  • Prior Authorization
  • Step Therapy
  • Patient Adherence Considerations

Break 10:15-10:30

Pharmacoepidemiology 10:30-11:30

  • Individual and Population Drug Safety
  • Prospective Drug Utilization Evaluation
  • Retrospective Drug Utilization Review
  • Drug Use Research Using Commercial Databases
  • Drug Use Research Using Federal Databases
  • Development of Drug Use Guideline

Pharmacoeconomics 11:30-12:00

  • Cost-of-Illness Analysis
  • Cost-Minimization Analysis
  • Cost-Benefit Analysis

Lunch 12:00-1:00

Pharmacoeconomics continued 1:00-2:00

  • Cost-Effectiveness Analysis
  • Cost-Utility Analysis
  • Quality of Life Evaluation 
  • Quality-Adjusted Life Years
  • Applications in Decision-Making

Break 2:00-2:15

Drug Pricing & Marketing 2:15-3:30

  • Brand and Generic/Biosimilar Drugs
  • Drug Product Life Cycle
  • Pricing Strategies
  • Pricing Surveys; Pricing Companies
  • Economic Complements and Substitutes
  • Specific Buyers’ Contracts (VA, 340b program)
  • Price Discrimination Abilities
  • Marketing Strategies
  • Patient Assistance Programs
  • Role of Direct-to-Consumer Advertising

Pricing Activity 3:30-4:30

Q&A | Review | Evaluations 4:30-4:45